4.7 Article

Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study

Esmee C. de Baat et al.

Summary: This study evaluated the risk and risk factors for heart failure in childhood cancer survivors and highlighted the impact of radiation therapy and anthracycline dose on the risk. These findings may have important implications for improving current treatment protocols and surveillance guidelines.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Review Oncology

Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification

Carmen Bergom et al.

Summary: Radiation therapy is crucial in cancer treatment, but radiation-induced cardiac dysfunction remains a concern. Utilizing advanced technology like cardiac imaging and cardiovascular risk assessment can help reduce cardiac risks and guide post-radiotherapy care. Further personalizing radiotherapy based on enhanced dosimetry and comprehensive cardiac toxicity data can minimize cardiac dysfunction.

JACC: CARDIOONCOLOGY (2021)

Article Oncology

Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer

Katelyn M. Atkins et al.

Summary: This cohort study explores the impact of radiation doses to cardiac substructures on major adverse cardiac events and mortality in patients with locally advanced non-small cell lung cancer. The findings suggest that dose exposure to the left anterior descending coronary artery may be an independent factor associated with adverse cardiac events and mortality, with significant interaction with baseline coronary heart disease status. Further validation and optimization of risk mitigation strategies are needed.

JAMA ONCOLOGY (2021)

Article Oncology

Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy

Katelyn M. Atkins et al.

Summary: This study found that MHD is insufficient to predict LAD V15Gy with confidence, and there is discordance between MHD and LAD V15Gy. For patients with locally advanced NSCLC, isolated low LAD V15Gy can significantly reduce the risk of MACE.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Review Oncology

Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions

Kathryn Banfill et al.

Summary: The impact of radiotherapy on the heart is a growing area of interest, with no consistent cardiac dose-volume constraints identified. While many lung cancer patients undergoing treatment have cardiovascular risk factors, there is limited evidence on the effects of radiotherapy on the heart in these patients.

JOURNAL OF THORACIC ONCOLOGY (2021)

Article Oncology

Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study

Suman Shrestha et al.

Summary: This study reevaluated survivors in the CCSS cohort using an improved HHybrid model, finding associations between heart RT doses and late cardiac disease risk. Updated risk estimates were generally consistent with prior estimates, but there were significant increases in cardiac disease risk in certain dose and volume categories with the updated dosimetry.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Oncology

Life Expectancy of Adult Survivors of Childhood Cancer Over 3 Decades

Jennifer M. Yeh et al.

JAMA ONCOLOGY (2020)

Article Oncology

A cardiac contouring atlas for radiotherapy

Frances Duane et al.

RADIOTHERAPY AND ONCOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Cardiac Diseases Following Childhood Cancer Treatment Cohort Study

Nadia Haddy et al.

CIRCULATION (2016)

Article Oncology

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma

David J. Cutter et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Oncology

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma

David J. Cutter et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Medicine, General & Internal

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

Sarah C. Darby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Oncology

DEVELOPMENT AND VALIDATION OF A HEART ATLAS TO STUDY CARDIAC EXPOSURE TO RADIATION FOLLOWING TREATMENT FOR BREAST CANCER

Mary Feng et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Oncology

Pediatric Cancer Survivorship Research: Experience of the Childhood Cancer Survivor Study

Wendy M. Leisenring et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Medicine, General & Internal

Chronic health conditions in adult survivors of childhood cancer

Kevin C. Oeffinger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)